• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-
-

2010 Warning Letters

Recently Posted | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996

Warning Letters issued in 2010

 

* Not issued: A close-out letter may issue when, based on FDA’s evaluation, the firm has taken corrective action to address the violations contained in the Warning Letter. This procedure applies to Warning Letters issued on or after September 1, 2009.

* N/A: Not applicable, the Warning Letter was issued prior to September 1, 2009.

Read more about warning and close-out letters

Posted on November 30, 2010

Letter Issue Date Company Name Issuing Office Subject Close Out Date
October 15, 2010 Prime Time Seafood, Inc Los Angeles District Office Seafood HACCP/CGMP for Foods/Adulterated June 27, 2011
October 14, 2010 Contract Pharmacal Corporation New York District Office CGMP for Finished Pharmaceuticals/Adulterated/Misbranded April 18, 2012
October 14, 2010 Blum's Spring Lake Fisheries Minneapolis District Office Seafood HACCP/CGMP for Foods/Adulterated/Misbranded July 29, 2011
October 14, 2010 Irish Acres Dairy LLC Detroit District Office Animals for Sale for Slaughter as Food/Adulterated February 07, 2011
October 13, 2010 Bos Dairy LLC Detroit District Office Animals for Sale for Slaughter as Food/Adulterated May 09, 2011
October 12, 2010 Longevity Plus, LLC Los Angeles District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Hormonal Health, LLC Los Angeles District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Dr. Rhonda Henry San Francisco District Office Unapproved New Drugs/Misbranded Not Issued *
October 12, 2010 Advanced Testing Laboratory Inc Cincinnati District Office CGMP for Finished Pharmaceuticals/Adulterated September 26, 2011
October 12, 2010 Evenbetternow, LLC Los Angeles District Office Unapproved New Drugs/Misbranded May 03, 2011


 

Contact FDA

301-796-8490
FDA's Office of Critical Path Programs
-
-
-